Resources

Chimeric antigen receptor (CAR) T-cell therapy is among the most promising breakthroughs in modern oncology. By genetically engineering a patient’s T lymphocytes to recognize and destroy cancer cells, CAR T-cell therapy has redefined what is possible in adoptive cellular immunotherapy.

To succeed, biotechs are rethinking how clinical research gets done. RWD, AI, and patient-centric strategies are no longer experimental; they’re emerging as the core toolkit for companies determined to accelerate progress while controlling risk.

The recent ISPOR Europe 2025 conference, held under the inspiring theme ‘Powering Value and Access Through Patient-Centered Collaboration

Real-world data (RWD) plays a crucial role in clinical research and decision-making, yet navigating its complexity remains a significant challenge. RWD typically comes from claims—open or closed—or from electronic health records (EHRs).

I recently had the opportunity to sit down with Danny Levine for an episode of his RARECast podcast  to discuss something I’m deeply passionate about: how real-world data (RWD) is transforming the landscape of rare disease research.

At the recent SCOPE Europe conference, I spoke about a fundamental shift redefining the future of clinical research.

When we think about the future of clinical research, it’s easy to picture gleaming technology, seamless data flows, and a world where trials are faster, smarter, and more inclusive. But let’s be honest. We’re not there yet. 

We’re proud to announce that our TriNetX LIVE™ platform was recognized as a Best of Show Finalist at the SCOPE Europe conference.

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.

Run time: 41mins. Clinical research is at a crossroads. The technology exists, the data is available, and the ambition is clear, but adoption of truly integrating Artificial Intelligence (AI) and data-driven trials often stalls due to risk, trust, and organizational inertia

Medication mapping to standardized terminologies is an important prerequisite for performing analytics on a federated EHR network. TriNetX LLC operates the largest such network in the world.

Run time: 29mins. How can clinical research move from talking about diversity to embedding representativeness as a foundation of trial design? In this episode of The Future Prescription: Inside the Trends, industry leaders explore how equitable design can transform science, improve patient outcomes, and set a new standard for compliance.